We cover cardiovascular disease in this episode. As part of that we talk about atherosclerosis, risk factors, end results of cardiovascular disease such as angina, strokes and myocardial...

2018年2月12日 · Cardiometabolic diseases include these cardiovascular conditions, plus others, such as insulin resistance, diabetes and non-alcoholic fatty liver disease. Cardiometabolic diseases tend to have a number of risk factors in common. “Cardiometabolic risk factors include, at minimum, abdominal obesity (waistline 40 inches or more in men, 35 inches ...

Find & Download Free Graphic Resources for Cartoon Heart Disease. 37,000+ Vectors, Stock Photos & PSD files. Free for commercial use High Quality Images

Cardiometabolic diseases are a group of common and often preventable chronic diseases that affect your cardiovascular system (heart and circulation or blood vessels) and your metabolic health. Let’s focus on four main connected cardiometabolic conditions: Nonalcoholic fatty liver disease (NAFLD) is a condition in which fat builds up in the liver.

Cardiometabolic diseases are a spectrum of interrelated chronic diseases that affect the cardiovascular system—the heart, blood circulation and blood vessels—and metabolic health. 1 These cardiometabolic diseases, like diabetes and obesity, are often interconnected but can have separate treatment plans from multiple health care providers ...

2022年8月18日 · An analysis shows less than 7% of adults in the US meet the criteria for optimal cardiometabolic health. Taking small steps to help control and improve key risk factors can reduce the odds of a heart attack or stroke.

2024年11月1日 · Cardiometabolic diseases (CMDs), a group of interconnected disorders including metabolic diseases, like obesity and type 2 diabetes mellitus (T2DM) coupled with cardiovascular complications such as ischemic heart disease (IHD) and heart failure (HF), are now recognized as the leading cause of death globally 1 with almost 18 million ...

2021年3月2日 · Deaths due to cardiometabolic diseases include the following cause-of-death categories: endocrine, nutritional, and metabolic (ENM) diseases (e.g., thyroid conditions, diabetes, hyperlipidemia, obesity); hypertensive heart disease (e.g., heart disease caused by prolonged exposure to high blood pressure); and ischemic heart disease and other ...

为此，2005年美国心脏协会提出了心血管代谢风险（cardiometabolic risk）及ASCVD的概念，而代谢性心血管病（cardiometabolic diseases）主要指代谢异常与心血管损害之间有较为明确的因果关系，且排除了结构性心血管病、心律失常和心肌病等病因，ASCVD为其主要表现，以冠心病、心脏性猝死、心力衰竭（心衰）等为主要结局，干预代谢紊乱可有效改善预后的一种临床综合征，也有学者称之为心血管代谢综合征（cardiometabolic syndrome）。

A new cardiometabolic-based chronic disease (CMBCD) model is presented that provides a basis for early and sustainable, evidence-based therapeutic targeting to promote cardiometabolic health and mitigate the development and ravages of cardiovascular disease.